CHICAGO and VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release third quarter 2026 financial results after the market closes on Wednesday, November 4, 2026.

A conference call and audio webcast will also be held on Wednesday, November 4, 2026, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.

Cautionary Note Regarding Forward-Looking Information

This press release may contain forward-looking statements within the meaning of applicable securities laws. Such statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those implied by such statements. Green Thumb Industries undertakes no obligation to update any forward-looking statements, except as required by applicable law.

About Green Thumb Industries
Green Thumb Industries Inc. (“Green Thumb”) is a leading national cannabis consumer packaged goods company and retailer headquartered in Chicago, Illinois. The company manufactures and distributes a portfolio of licensed, branded cannabis products, including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s and Good Green. Green Thumb also owns and operates RISE Dispensaries, a rapidly growing national retail chain. Green Thumb serves millions of patients and customers each year with a mission to promote well-being through the power of cannabis while giving back to the communities it serves. Established in 2014, Green Thumb has manufacturing facilities and retail stores across 14 U.S. markets, employing approximately 5,000 people. More information is available at www.gtigrows.com.

Investor Contact:
Andy Grossman
EVP, Capital Markets & Investor Relations
InvestorRelations@gtigrows.com
888-406-1143

Media Contact:
GTI Communications
media@gtigrows.com

TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional results from its diamond drilling program at the Company’s Goliath Gold Complex, which includes the Goliath, Goldlund and Miller Deposits. The drill program, of which approximately 31,971 metres of the expanded 35-000 metre program have been completed, is focused on infilling and testing the extension of mineralization within Zone 4 of the Goldlund Deposit. The results presented in this news release include 3,603 metres of diamond drilling in 10 drill holes (GL-26-031 to GL-26-040) (Figures 1, 2 and 3; Tables 1 and 2).

Selected drill intersections from diamond drill holes at the Goldlund Deposit in this news release are further detailed in Table 1 and include:

  • 14.07 g/t gold over 7.0 metres (from 187.0 to 194.0 metres), including 95.70 g/t gold over 1.0 metres in drill hole GL-26-034; additionally, 9.76 g/t gold over 8.0 metres (from 170.0 to 178.0 metres), including 74.10 g/t gold over 1.0 metres, 2.84 g/t gold over 13.0 metres (from 205.0 to 218.0 metres), including 21.70 g/t gold over 1.2 metres, 53.00 g/t gold over 1.0 metres (from 74.0 to 75.0 metres), and 0.55 g/t gold over 29.7 metres (from 243.5 to 273.2 metres) including 7.61 g/t gold over 1.2 metres in the same hole;
  • 2.23 g/t gold over 15.5 metres (from 123.5 to 139.0 metres), including 40.50 g/t gold over 0.5 metres and 3.97 g/t gold over 0.8 metres in drill hole GL-26-032; additionally, 1.49 g/t gold over 9.1 metres (from 433.9 to 443.0 metres), including 6.50 g/t gold over 0.7 metres and 9.25 g/t gold over 0.5 metres in the same hole;
  • 1.25 g/t gold over 22.0 metres (from 166.0 to 188.0 metres), including 40.50 g/t gold over 0.5 metres in drill hole GL-26-033; additionally, 0.84 g/t gold over 42.8 metres (from 245.7 to 288.5 metres), including 7.04 g/t gold over 1.3 metres and 3.91 g/t gold over 1.0 metres in the same hole; and
  • 1.51 g/t gold over 17.1 metres (from 218.9 to 236.0 metres), including 13.80 g/t gold over 0.6 metres and 5.98 g/t gold over 1.0 metres in drill hole GL-26-039A; additionally, 2.04 g/t gold over 6.2 metres (from 196.2 to 202.4 metres), including 15.50 g/t gold over 0.6 metres in the same hole.

Kevin Bullock, President, CEO & Director of NexGold, commented: “I am pleased with the additional assay results from our drill program at Goldlund. This program continues to demonstrate grade continuity at depth, but within reach of a potential open pit. Grade tenor and thicknesses continue to build confidence that mineralization continues at depth and is consistent with previous drill results. Our continued drilling progress at Goldlund further supports our objectives for this program – to infill and test the extension of mineralization in Zone 4 – which is expected to contribute to refinement of our geological model and may inform future Mineral Resource assessments. We expect to complete the balance of the 35,000-metre program by the end of 2026 and will continue to provide updates as results become available.”

Mineralization at the Goldlund Deposit is generally characterized by quartz stockwork veining within sub-vertical granodiorite sills. Zone 4 at the Goldlund Deposit includes broad intervals of mineralized intermediate-mafic volcanic rocks with multiple porphyry and granodiorite intrusions. The drill results summarized in this news release, together with previously announced drill results, provide additional support and information relevant to the interpretation of grade continuity within Zone 4. These results are expected to contribute to ongoing refinement of the geological model and may support future evaluation of Mineral Resource classification, subject to additional drilling, data verification, and completion of further technical studies.

Drill holes completed as part of this program have been distributed across the strike extent of Zone 4, with the holes highlighted in this news release located from the central to southeastern portion of the zone. The results provide additional information supporting the Company’s current geological interpretation of mineralization within Zone 4 and provide additional information regarding the continuity of mineralization between drill sections. Additional drilling is planned to further evaluate mineralization along strike and down dip and to inform Mineral Resource assessments.

Figure 1: Plan map showing the location of the Goldlund Zone 4 infill drill holes

Plan map showing the location of the Goldlund Zone 4 infill drill holes

Figure 2: A cross-section through the Goldlund Deposit showing the location of the drill holes (GL-26-030B to GL-26-032 and GL-26-038 to GL-26-040) reported in this news release

A cross-section through the Goldlund Deposit showing the location of the drill holes (GL-26-030B to GL-26-032 and GL-26-038 to GL-26-040) reported in this news release

Figure 3: A cross-section through the Goldlund Deposit showing the location of the drill holes (GL-26-033 to GL-26-035 and GL-26-037) reported in this news release

A cross-section through the Goldlund Deposit showing the location of the drill holes (GL-26-033 to GL-26-035 and GL-26-037) reported in this news release

Table 1: Highlighted drill intercepts from drill holes in this news release

Drill Hole ID Target/Zone From (m) To (m) Interval (m) Au (g/t)
GL-26-031 Zone 50 66.8 69.6 2.8 2.05
And Zone 4 300.0 301.0 1.0 42.30
And Zone 4 309.0 326.0 17.0 0.30
including   325.0 326.0 1.0 2.42
And Zone 4 355.1 372.9 17.8 0.36
GL-26-032 Zone 50 123.5 139.0 15.5 2.23
Including   123.5 124.0 0.5 40.50
and including   136.2 137.0 0.8 3.97
And Zone 4 433.9 443.0 9.1 1.49
Including   439.8 440.5 0.7 6.50
and including   442.5 443.0 0.5 9.25
GL-26-033 Interzone 21.0 27.0 6.0 1.01
Including   21.0 22.0 1.0 3.85
And Interzone 38.0 39.0 1.0 7.26
And Zone 4 166.0 188.0 22.0 1.25
Including   174.5 175.0 0.5 40.50
And Zone 4 245.7 288.5 42.8 0.84
Including   249.5 250.8 1.3 7.04
and including   273.0 274.0 1.0 3.91
And Zone 4 293.8 300.0 6.2 1.19
Including   299.0 300.0 1.0 3.09
And Zone 4 309.0 314.7 5.7 2.13
Including   310.0 311.0 1.0 10.70
GL-26-034 Interzone 74.0 75.0 1.0 53.00
And Zone 4 170.0 178.0 8.0 9.76
Including   173.0 174.0 1.0 74.10
And Zone 4 187.0 194.0 7.0 14.07
Including   187.0 188.0 1.0 95.70
And Zone 4 205.0 218.0 13.0 2.84
Including   216.8 218.0 1.2 21.70
And Zone 4 223.0 232.9 9.9 0.70
Including   223.0 224.0 1.0 4.18
And Zone 4 243.5 273.2 29.7 0.55
Including   272.0 273.2 1.2 7.61
And Zone 4 299.0 304.5 5.5 0.95
Including   303.5 304.5 1.0 4.01
GL-26-035 Interzone 85.5 91.5 6.0 1.02
Including   90.0 91.5 1.5 4.05
And Zone 4 195.0 212.0 17.0 0.46
Including   207.0 208.0 1.0 2.92
And Zone 4 219.4 225.0 5.6 0.57
And Zone 4 239.0 253.8 14.8 0.43
GL-26-036 Zone 4 146.0 149.0 3.0 1.02
Including   146.0 146.7 0.7 2.99
GL-26-037 Zone 4 176.5 182.0 5.5 1.07
Including   181.0 182.0 1.0 3.17
And Zone 4 195.0 209.0 14.0 0.62
Including   206.0 207.0 1.0 2.31
GL-26-038 Zone 4 178.0 186.0 8.0 0.65
Including   185.0 186.0 1.0 2.52
And Zone 4 192.9 193.4 0.5 26.80
GL-26-039A Zone 4 196.2 202.4 6.2 2.04
Including   201.8 202.4 0.6 15.50
And Zone 4 218.9 236.0 17.1 1.51
Including   218.9 219.5 0.6 13.80
and including   225.5 226.5 1.0 5.98
GL-26-040 Zone 4 216.1 227.6 11.5 0.81
Including   222.6 223.6 1.0 3.58

Notes:
1. Reported intervals are drilled core lengths and do not indicate true widths. True widths typically vary from 50 to 75% of the interval length, except for hole GL-26-033, where true width is estimated from 25 to 50% of interval length due to the steeper inclination drilled.
2. For duplicate samples, the average grade was used to calculate the intersection grade. All grades are uncapped.

Table 2: Locations and orientations of drill holes in this news release

Drill Hole ID Easting Northing Elevation (m) Length (m) Azimuth Inclination
GL-25-031 546884 5527816 415 450 131 -46
GL-25-032 546884 5527816 415 501 128 -55
GL-25-033 546699 5527562 418 402 140 -70
GL-25-034 546768 5527647 418 405 129 -54
GL-26-035 546768 5527647 418 372 129 -45
GL-26-036 546691 5527494 410 192 128 -52
GL-26-037 546694 5527607 415 327 132 -45
GL-26-038 547033 5527739 423 300 120 -46
GL-26-039A 547072 5527762 426 327 121 -46
GL-26-040 547102 5527764 427 327 119 -45

Note: Drill hole locations reported as Universal Transverse Mercator NAD83 Zone 15N coordinates

QA / QC

The Company has implemented a quality assurance and quality control (“QA/QC”) program to ensure sampling and analysis of all exploration work is conducted in accordance with the CIM Exploration Best Practices Guidelines. Drill core is sawed in half with one-half of the core sample dispatched to the Activation Laboratories Ltd. laboratory in Dryden, Ontario. The other half of the core is retained for future assay verification and/or metallurgical testing. Other QA/QC procedures include the insertion of blanks and Canadian Reference Standards for every tenth sample in the sample stream. A quarter core duplicate is assayed every 20th sample. The laboratory, which is independent of the Company, has its own QA/QC protocols, running standards and blanks with duplicate samples in each batch stream. Additional checks are routinely run on anomalous values including gravimetric analysis and pulp metallic screen fire assays. Gold analysis is conducted by lead collection, fire assay with atomic absorption, and/or gravimetric finish on a 50-gram sample. Check assays are conducted at a secondary independent ISO certified laboratory (in this case AGAT Laboratories located in Mississauga, Ontario) following the completion of a program.

Qualified Person

Paul McNeill, P.Geo., VP Exploration of NexGold, is a “Qualified Person” as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. McNeill has reviewed the available data, composites and QA/QC information related to the drill program and approved the scientific and technical disclosure contained in this news release on behalf of NexGold.

About NexGold Mining Corp.

NexGold is a gold-focused company with assets in Canada and Alaska, including the Goldboro Gold Project in Nova Scotia, the Goliath Gold Complex (which includes the Goliath, Goldlund and Miller deposits) in Northwestern Ontario, and additional exploration projects across Canada. NexGold also holds a 100% interest in the high-grade Niblack copper-gold-zinc-silver VMS project in southeast Alaska. NexGold is committed to ongoing, meaningful engagement with regional communities and Indigenous Nations to support sustainable development, safe operations, and shared economic and social benefits.

Further details about NexGold, including a Feasibility Study for the Goldboro Gold Project and a Prefeasibility Study for the Goliath Gold Complex, are available under the Company’s issuer profile on www.sedarplus.ca and on NexGold’s website at www.nexgold.com.

Contact:

Kevin Bullock
President & CEO
(416) 214-4654
kbullock@nexgold.com
Greg DiTomaso
Investor Relations
(647) 547-5357
gditomaso@nexgold.com


Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and “forward-looking statements” within the meaning of applicable United States securities laws (collectively, “forward-looking information”). Forward-looking information relates to future events or future performance and reflects management’s expectations and assumptions as of the date of this news release.

Forward-looking information contained in this news release includes, but is not limited to statements regarding the Company’s plans and objectives for the Goldlund drill program; the expected completion of the 35,000-metre drill program by the end of 2026; planned drilling to evaluate mineralization along strike and down dip; the contribution of drilling results to refinement of the Company’s geological model; the potential use of drilling results in future Mineral Resource assessments and evaluation of Mineral Resource classification; and the timing and availability of additional drilling results.

Forward-looking information is often, but not always, identified by words and phrases such as “plans”, “expects”, “is expected”, “scheduled”, “estimates”, “intends”, “anticipates”, “believes”, “targets”, “potential”, “may”, “could”, “should”, “would”, “will” and similar words and expressions.

Forward-looking information contained in this news release is based on certain assumptions that management considers reasonable as of the date of this news release, including that exploration activities will proceed on the anticipated schedules; that contractors, personnel, equipment and supplies necessary to complete the drill program will remain available on acceptable terms; that assay and other results will be received within anticipated timeframes; that the Company’s geological interpretations based on existing information are reasonable; and that the Company will have sufficient financial resources to complete its planned exploration activities.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, among others: risks that exploration activities, including drilling, may not accurately predict the continuity, grade or extent of mineralization; that future drilling results may not support the Company’s geological interpretations or changes to Mineral Resources estimates or classifications; delays in drilling, receipt of assay results or other exploration activities; the availability of financing, personnel, equipment and contractors; fluctuations in commodity prices, exchange rates and market conditions; environmental, Indigenous, community, permitting and regulatory risks; health and safety risks; and other risks described in the Company’s public disclosure documents available under its profile on SEDAR+ at www.sedarplus.ca.

Although the Company believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that such information will prove to be accurate, and actual results and future events may differ materially from those anticipated. Readers should therefore not place undue reliance on forward-looking information. The forward-looking information contained in this news release is provided as of the date hereof, and the Company undertakes no obligation to update or revise such forward-looking information except as required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/4356fdeb-b77b-4642-bfb5-91022466b000
https://www.globenewswire.com/NewsRoom/AttachmentNg/4cb356cf-0163-4da1-bd32-a0f9bb696bb4
https://www.globenewswire.com/NewsRoom/AttachmentNg/2536866c-f3c7-476e-8a82-7ec7b7f764cb

ROUYN-NORANDA, Quebec, Sept. 23, 2026 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Company”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to present its operational report for the month of August 2026 for its Sleeping Giant gold mine, located north of Amos, Quebec. The results demonstrate a marked acceleration of the mine’s restart plan, driven by an increase in mill processing and continuous improvement in the head grades fed.

Highlights:

  • Gold production increase: Production of 344 ounces of gold during the month, representing a 91% increase compared to the 180 ounces produced in July.
  • Tonnage and grades progressing at the mill: Processing 6,209 tonnes of ore at a growing average grade of 1.94 g/t.
  • Continuous increase in underground workforce: Hiring of 6 new miners, bringing the total workforce dedicated to the mine to 149 workers, allowing for accelerated development.
  • Underground infrastructure advancement: Completion of 175 m of track drifts and drawpoints, as well as 88 m of sub-levels.
  • Finalization of the mining camp in September: 123 rooms will be available to accommodate the personnel required to achieve objectives.
  • Hiring at the mill: A second shift team has been recruited. It will be fully operational in October, enabling day and night mill operations on a 4-3 schedule. This team optimization will allow the processing of up to 12,800 tonnes of ore per month.
  • Conclusion of an official strategic partnership: Abcourt will now be able to welcome trainees from the Centre de formation professionnelle de la Baie-James (CFPBJ).

Table 1: Comparison of Mill Performance Indicators and Gold Production

Operational Indicator July 2026 August 2026 Evolution
Tonnes milled 4,736 t 6,209 t + 1,473 t (+ 31.1 %)
Average grade (g/t) 1.36 g/t 1.94 g/t + 0.58 g/t (+ 42.6 %)
Recovery rate 86.8 % 88.9 % + 2.1 %
Ounces produced 180 oz 344 oz + 164 oz (+ 91%)
Gold Pours 715 oz * 201 oz See note Below

* Explanatory Note: The high gold pour recorded in July (715 oz) resulted from a cleanup of the inventory accumulated in the milling circuits during a technical transition phase. The August data accurately reflects the restart of a regular and stable production cycle, supported by the solid progression of tonnage and grade.

UNDERGROUND:

Workforce Optimization and Underground Production

Recruitment continued in August with the integration of 6 new workers, bringing the team dedicated to the mine to 149 employees. In parallel, the training partnership with Technica is bearing fruit: 2 trainers are currently supervising 10 apprentice-miners, with the objective of developing our own internal pool of qualified workforce.

This increase in underground personnel has allowed several key work areas to progress.

Table 2: Current Status and Planning of Mining Sectors

Sector Zone Development Progress Planned Production Period
295-DAC5 512 m / 790 m Mining in progress; completion planned for January 2027
235-Zone 20 481.1 m / 516 m September – December 2026
235-Zone 3 251.22 m / 405 m To come (post-development)
355-Zone 3N Beginning of development. + 63.5 m * To Come
235-Zone 4_5 Ore drift is completed. Track drift started at the end of August 2026 (+ 47.15 m) ** Multi-Year

* Note: No total data available for 355-Z3N (concept currently being finalized).
** Note: Overall data for zone 4_5 pending block model (BM).

Mutually Beneficial Partnership for the Next Generation of Miners

An alliance with the Centre de formation professionnelle de la Baie-James (CFPBJ) allows Abcourt to counter the labor shortage by welcoming freshly trained interns. Students benefit from a concrete immersion at the Sleeping Giant mine, with room and board and transportation included. For the company, this structuring program secures a direct pool of qualified workers to support the acceleration of its underground operations.

Geology and Exploration

Definition and resource conversion drilling activities actively focused on levels 355 and 915 with two drills in action. During the month, 25 holes were completed for a total of 3,064 meters of core. A total of 2,427 core samples were shipped for analysis. The Company also received and integrated 3,876 assay results into its database, allowing continuous updates to its block models and 3D modeling to optimize future mining plans.

Infrastructure, IT and Environment

Regarding surface infrastructure, Abcourt began excavation and preventive maintenance work at the tailings pond as well as a reorganization of the interior yard. The IT department carried out major optimizations, including the relocation of the GuideTI server to the Sleeping Giant site, the installation of a secondary Starlink system to guarantee network redundancy, and the configuration of a new Web server dedicated to tracking production and miners’ bonuses.

Perspectives

Abcourt management is fully engaged in preparing its 2026/2027 budget. No major capital expenditure (CAPEX) is required in the short term, with absolute priority remaining focused on increasing production rates and achieving maximum operational critical mass at the Sleeping Giant mine. A regular and scheduled maintenance plan will be carried out in due course but will not significantly affect production.

Pascal Hamelin, President and Chief Executive Officer of Abcourt, states: “The 91% increase in our gold production in August confirms the acceleration of the ramp-up at Sleeping Giant. This momentum continues into September, with our teams having already successfully hoisted 5,706 tonnes of ore and milled 4,761 tonnes. Thanks to the continuous arrival of labor and the addition of a second shift at the mill, we are building the critical mass to operate day and night starting this fall. Our absolute priority remains the constant increase of our production rates to maximize all our volumes.”

Qualified Person: Pascal Hamelin, P. Eng., President and Chief Executive Officer of the Company, has reviewed and approved the technical information contained in this press release. Mr. Hamelin is a Qualified Person as defined by National Instrument 43-101.

About Abcourt Mines Inc.

Abcourt Mines Inc. is a Canadian gold development company with strategic properties located in northwestern Quebec, Canada. Abcourt owns the Sleeping Giant mine and mill and the Flordin property where it concentrates its activities.

For further information on Abcourt Mines Inc., please visit our website www.abcourt.ca and the documents filed under our profile on the SEDAR+ website www.sedarplus.ca.

Pascal Hamelin Dany Cenac Robert
President and Chief Executive Officer VP Communication and Corporate Development
T: (819) 768-2857 T: (514) 722-2276, ext. 456
Email: phamelin@abcourt.com Email: ir@abcourt.com
   

FORWARD-LOOKING STATEMENTS

Certain information contained in this press release may constitute “forward-looking information” within the meaning of Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “aims”, “expects”, “projects”, “intends”, “anticipates”, “estimates”, “could”, “should”, “likely”, or variations of such words and phrases or statements specifying that certain acts, events or results “could”, “should” occur, “will occur” or “will be achieved” or other similar expressions. Forward-looking statements are based on Abcourt’s estimates and are subject to known and unknown risks, uncertainties and other factors that could cause actual results, level of activity, performance or achievements of Abcourt to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Forward-looking statements are subject to business and economic factors and uncertainties, as well as other factors that could cause actual results to differ materially from those forward-looking statements, including relevant assumptions and risk factors set forth in Abcourt’s public documents, available on SEDAR+ at www.sedarplus.ca. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Although Abcourt believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements. Unless required by applicable securities laws, Abcourt disclaims any intention or obligation to update or revise any of these forward-looking statements or information, whether in light of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release

Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange

Highlights

  • The Company is actively advancing plans for a potential ibogaine clinical trial in Texas for Opioid Use Disorder (OUD).
  • Texas Ibogaine Research Corporation (TIRC), a dedicated U.S. subsidiary of Psyence BioMed, has been established for its planned ibogaine development activities in the US.
  • Psyence BioMed has agreed to invest up to US$5 million in PsyLabs, of which US$2.4 million has been committed, to support scientific development and pharmaceutical-grade manufacturing capabilities relevant to the planned U.S. program.
  • Psyence BioMed and PsyLabs have agreed to a value-matched share exchange with a transaction value of approximately US$9 million on each side.

NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company developing nature-derived neuroplastogen therapeutics, today announced that it has agreed to make a cash investment of up to US$5 million in Psyence Labs Ltd. (“PsyLabs”), together with a value-matched share exchange between the two companies. The transactions are intended to support the scientific, manufacturing and development capabilities required for Psyence BioMed’s planned U.S. ibogaine program.

TIRC, registered and headquartered in Texas, has been established to provide a dedicated corporate structure through which the Company can coordinate its planned U.S. regulatory, clinical and development activities involving pharmaceutical-grade ibogaine.

The Company is currently evaluating the feasibility and design of a potential ibogaine clinical trial in Texas. Any clinical program would be subject to protocol development, regulatory review and authorization, institutional approvals, funding, site selection and other customary requirements.

Texas has emerged as an important state for publicly supported ibogaine research. Psyence BioMed believes that establishing a dedicated presence in the state positions the Company to participate in this developing research environment while building the regulatory and clinical infrastructure required for a potential U.S. development program.

Strategic Investment and Share Exchange

To support its planned development activities, Psyence BioMed has agreed to invest up to US$5 million in PsyLabs. The investment is intended to fund scientific work and the continued development of pharmaceutical-grade ibogaine manufacturing capabilities relevant to Psyence BioMed’s U.S. program. Psyence BioMed has irrevocably committed to subscribe for US$2.4 million (936 PsyLabs ordinary shares at US$2,564 per share, based on a pre-money equity valuation of PsyLabs of US$54 million) under its pro rata pre-emption entitlement in PsyLabs’ current financing round. The balance of up to US$2.6 million is a backstop commitment to subscribe for shares in that financing round not taken up by other PsyLabs shareholders, in up to two tranches of up to US$1.3 million each, payable upon certain milestones being achieved and other customary conditions. If the milestone tranches have not been called and completed by December 31, 2026, Psyence BioMed’s obligation to fund them will lapse.

In addition to the abovementioned investment, the Company and PsyLabs have also agreed to a reciprocal share-for-share exchange, with each component valued at approximately US$9 million, subject to applicable corporate and regulatory approvals, required Nasdaq notifications and other customary closing conditions. The share exchange agreement may be terminated by any party if closing has not occurred by November 30, 2026. Under the agreed terms:

  • Psyence BioMed will issue 1,497,500 common shares to PsyLabs, representing approximately US$8.99 million in transaction value based on a deemed issue price of US$6.00 per PBM share; and
  • PsyLabs will issue 3,473 ordinary shares to Psyence BioMed, representing an equivalent transaction value of approximately US$8.99 million based on an implied equity valuation of PsyLabs of US$60 million derived from an independent third-party valuation.

Psyence BioMed is making the cash investment, and will hold the PsyLabs shares to be issued under the share exchange, through its wholly-owned subsidiary, Psyence Biomed II Corp. The share exchange increases each company’s ownership interest in the other. Immediately prior to the transactions, PsyLabs held approximately 30.22% of Psyence BioMed’s issued and outstanding common shares, and Psyence BioMed held approximately 29.17% of PsyLabs’ issued and outstanding shares. Immediately following completion of the share exchange and the committed portion of the cash investment, PsyLabs will hold approximately 49.89% of Psyence BioMed’s issued and outstanding common shares, and Psyence BioMed will hold approximately 41.13% of PsyLabs’ issued and outstanding shares. The cash investment and the share exchange are related-party transactions. Psyence BioMed believes the transactions will more closely align its clinical and regulatory development activities with PsyLabs’ pharmaceutical-grade manufacturing and supply capabilities.

“Access to pharmaceutical-grade ibogaine is fundamental to the U.S. program we are planning,” said Jody Aufrichtig, Chief Executive Officer of Psyence BioMed and TIRC. “Our investment in PsyLabs, together with the share exchange, is intended to align Psyence BioMed more closely with the manufacturing and supply capabilities we believe a regulated clinical program will require, while TIRC provides the dedicated U.S. structure through which we intend to advance that program. Our objective is to advance this program responsibly, supported by rigorous clinical research and pharmaceutical-grade manufacturing.”

“TIRC is intended to bring greater coordination to the regulatory, clinical and operational components of our planned U.S. program,” said Dr. John Thorne, Project Lead of TIRC. “We are now evaluating the requirements for a potential clinical trial, including the development plan, regulatory pathway, manufacturing documentation and necessary clinical capabilities.”

“PsyLabs has invested significant time and expertise in developing a controlled supply and manufacturing platform for pharmaceutical grade ibogaine,” said Tony Budden, Chief Executive Officer of PsyLabs. “This investment is intended to allow us to further develop that capability in support of Psyence BioMed’s planned U.S. program and the quality requirements associated with regulated clinical research.”

TIRC will initially draw upon Psyence BioMed’s existing legal, administrative and financial resources, with corporate oversight that includes Chief Financial Officer Warwick Corden-Lloyd and the Company’s in-house legal function.

ABOUT PSYENCE BIOMED

Psyence Biomedical Ltd. (Nasdaq: PBM) is a Nasdaq-listed company with its subsidiary, Texas Ibogaine Research Corporation, headquartered in Texas. It is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in neuroplastogen-based therapeutics and the manufacture of pharmaceutical-grade drug candidates. It is the first life sciences biotechnology company focused on developing nature-derived, non-synthetic psilocybin and ibogaine-based neuroplastogen medicine to be listed on Nasdaq. The Company is dedicated to addressing unmet mental health needs and is committed to an evidence-based approach to developing safe, effective and FDA-approved nature-derived neuroplastogen treatments across a range of mental health disorders.

ABOUT PSYLABS

PsyLabs is a neuroplastogen active pharmaceutical ingredient development company, federally licensed in its operating jurisdiction to cultivate, extract and export psilocybin mushrooms and other neuroplastogen compounds, including psilocybin, psilocin, mescaline, ibogaine and dimethyltryptamine, to lawful medical and research markets. PsyLabs operates from an ISO 22000 and GMP-compliant facility, with a focus on natural compound purification, regulatory support and global distribution. www.psylabs.life

CONTACTS

Psyence Biomedical Ltd. · ir@psyencebiomed.com · media@psyencebiomed.com · info@psyencebiomed.com · +1 416-477-1708

Investor contact: Michael Kydd, Investor Relations Advisor — michael@psyencebiomed.com

FORWARD-LOOKING STATEMENTS

This communication contains forward-looking statements within the meaning of applicable securities laws, including the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the proposed share exchange and the proposed US$5 million cash investment by Psyence BioMed into PsyLabs and their anticipated terms, pricing, timing, completion and effects; the application of the proceeds of that investment; the resulting shareholdings of Psyence BioMed and PsyLabs in one another; the formation, capitalization, funding and intended role of TIRC; the Company’s ability to secure pharmaceutical-grade drug substance and the regulatory documentation required to support a United States program; the evaluation, funding, design, timing and conduct of any clinical trial in Texas; the Company’s ability to obtain and maintain required registrations, permits, quotas and licenses; its ability to participate in federal or state ibogaine programs; and its expected role in future research, development and commercialization activities relating to ibogaine. Such statements may be identified by words including will, expects, intends, plans, anticipates, believes, estimates and similar expressions.

These statements rest on assumptions regarding government policy, continued interest in regulated neuroplastogen research, the availability of lawful development pathways, and the Company’s ability to maintain licenses, permits, supply arrangements and third-party relationships. Risks and uncertainties that could cause actual results to differ materially include: that the investments and share exchange or the corporate arrangements described are not completed on the terms or timetable expected, or at all; that required board, shareholder, regulatory or stock exchange approvals are not obtained; dilution to existing shareholders and the concentration of ownership resulting from the share exchange; that the share exchange and the cash investment are transactions between related parties, and that the terms agreed may differ from those that would be agreed between unrelated parties; that the US$6.00 per PBM share price at which PBM shares are issued under the exchange may not be indicative of the value at which those shares can be realized; that the valuations used to price the exchange and the cash investment are not indicative of realizable value; changes in law, regulation or enforcement priorities in the United States, Southern Africa or elsewhere; the continuing status of ibogaine as a controlled substance; clinical, regulatory and approval risk; competition and market adoption risk; financing risk; and the Company’s ability to maintain compliance with Nasdaq continued listing standards. This list is not exhaustive. These risks should be considered together with the risk factors described in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the fiscal year ended March 31, 2026 and in the Company’s other filings with the U.S. Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Readers should not place undue reliance on forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to update such statements.

The Company makes no medical, treatment or health benefit claims regarding its proposed products. The U.S. Food and Drug Administration, Health Canada and other regulatory authorities have not approved ibogaine or the Company’s other neuroplastogen compounds for therapeutic use, and their safety and efficacy have not been established through authorized clinical research. Rigorous scientific research and clinical trials are required. Any references to ibogaine stock, inventory or doses are the Company’s best estimates only. References to GMP-compliant mean production in a facility designed, operated and controlled in accordance with applicable Good Manufacturing Practice standards, and do not themselves constitute a representation of formal certification or approval by any regulatory authority unless expressly stated. References to a planned clinical trial describe an activity under evaluation only; no trial has been commenced, and no regulatory application in respect of it has been filed or accepted. This communication is not an offer to sell or a solicitation of an offer to buy any securities.

Geochemical and geophysical results expand known target footprints and support district-scale exploration potential across TDG’s 100%-owned Toodoggone mineral claims

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — TDG Gold Corp. (“TDG” or the “Company”) (TSXV: TDG | OTCQX: TDGGF) reports that interim results from its 2026 regional exploration program have expanded and better-defined exploration target areas at Baker–North Quartz, Black Gossan and Price–Trident. Each target area is characterized by kilometre-plus-scale geophysical responses or groupings of responses, located within TDG’s 100%-owned mineral claims in a corridor stretching northwest from Amarc-Freeport’s Aurora gold-rich copper porphyry discovery in BC’s Toodoggone District.

The results extend the exploration footprint beyond historical showings and support evaluating multiple potential mineralizing centres across an approximately 15-kilometre prospective corridor extending northwest of the Aurora Complex (Figure 1). Integrated soil geochemistry has identified additional gold- and copper-anomalous areas, the potential of which is supported by geophysical anomalies, providing a common technical basis for comparing and prioritizing opportunities across the corridor.

Key results

  • Baker–North Quartz: Gold and copper soil anomalies extend across several kilometres, while preliminary modelling identifies separate induced polarization (“IP”) chargeability responses distributed over an approximately 3.5-kilometre span. These responses extend the area of interest beyond the historical Baker high-grade gold-copper-silver mine workings and are not interpreted to be a single continuous body, rather a complex of anomalies.
  • Black Gossan: Preliminary modelling outlines a pronounced chargeability response with an approximately 2.1-kilometre horizontal extent in section, associated with relatively low resistivity, mapped alteration, soil geochemistry anomalies and magnetic contrasts.
  • Price–Trident: Copper and gold soil enrichment, intrusive geology and a local magnetic feature are associated with separate shallow and deeper chargeability responses across an approximately 1.45-kilometre span.

Remaining 2026 fieldwork, outstanding assays and final geophysical interpretations will support target ranking, with emphasis on geological setting, geochemical coherence, potential for near-surface mineralization and support from multiple independent datasets.

“The significance of this work is the combination of scale and multiple opportunities within one wholly-owned corridor,” said Paul Geddes, TDG’s SVP Business Development & Strategy. “A consistent technical framework allows us to compare those opportunities and identify where the strongest evidence comes together. That provides a better basis for selecting where to focus the next stage of exploration.”

A Corridor-Scale Strategy for Target Prioritization

The 2026 program integrates soil geochemistry, direct-current induced polarization (“DCIP”) and passive magnetotellurics across TDG’s 100%-owned mineral claims covering an area that encompasses TDG’s mineral-resource-stage Shasta project (PEA initiated June 2026), Aurora West and Baker, and extends as far north as the Saunders target (Figure 1). It represents the first comprehensive assessment of the broader corridor using consistent geochemical and geophysical coverage, looking beyond historical showings to determine whether they represent isolated occurrences or surface expressions of larger mineralized systems.

The principal exploration model is a corridor containing multiple intrusive-related hydrothermal centres and associated epithermal systems. Of particular interest are telescoped environments, where younger, shallower gold-rich mineralization may overprint earlier copper–gold porphyry system(s).

The regional alignment of Aurora West, Shasta, Newberry, Price–Trident, Black Gossan, Baker–North Quartz, and emerging targets farther north, defines a northwest-trending corridor with demonstrated copper, gold and silver endowment. TDG’s integrated approach is intended to identify the strongest near-surface opportunities and determine where multiple datasets support priority targets for potential drill testing.

Soil Survey: Expanding Target Footprints

3,455 soil samples have been collected against an expanded plan of approximately 5,000 samples.

Phase I established regional reconnaissance coverage using 200-by-200-metre and 200-by-400-metre sampling. Its purpose was to evaluate previously underexplored ground and identify new gold, copper and pathfinder-element anomalies.

Phases II and III are providing detailed follow-up through predominantly 100-by-100-metre sampling, locally with 50-by-50-metre infill, in areas of interest. This closer-spaced coverage is designed to refine anomaly boundaries, establish internal trends and identify the best locations for potential drill testing.

Results received to date demonstrate that the geochemical footprints around several historical occurrences are substantially broader than the individual showings that originally defined them. Around Baker–North Quartz, anomalous gold and copper values are distributed across several kilometres, extending the target well beyond the former Baker mine workings. Additional anomalous areas have been identified through Price–Trident and northward along the corridor.

The soil data also identify new areas of gold and copper enrichment where no established target had previously been defined (Figure 1). These anomalies may represent surface expressions of previously unrecognized mineralizing centres and allow TDG to evaluate the continuity of prospective trends between known occurrences.

North of Trident, emerging soil anomalies extend the investigation toward the property boundary and occur along the broader regional trend that continues toward Finlay Minerals’ (Freeport JV) neighbouring “Gold” target. The neighbouring occurrence is referenced for regional geological context only and is not necessarily indicative of mineralization on TDG’s property.

Geophysics: Investigating the Systems Below Surface

The 2026 geophysical program comprises approximately 55 line-kilometres of DCIP across eight regional lines, with approximately 48 line-kilometres completed and one seven-kilometre line remaining. The lines provide consistent, large-area coverage across the corridor, extending beyond individual historical showings.

The program also includes ground-based passive magnetotelluric data, acquired to provide complementary information on subsurface resistivity and the possible deeper architecture of the mineralizing systems.

Integrated IP, resistivity and magnetotelluric data help evaluate potential sulphide-bearing rocks, alteration, intrusive contacts and structures below surface. Preliminary modelling shows associations with known occurrences and soil anomalies, allowing TDG to assess target scale and prioritize areas supported by multiple independent datasets for potential drilling.

Target Findings

Baker–North Quartz: Expanded Footprint and Multiple Responses

The 2026 soil survey has expanded the gold and copper footprint around Baker–North Quartz to several kilometres, well beyond the area historically explored around the Baker veins.

Preliminary DCIP inversion modelling identifies several separate chargeability responses across an approximately 3.5-kilometre span. These responses occur within a broader magnetic low containing distinct internal magnetic features. They are not presently interpreted as one continuous body but collectively demonstrate that the broader Baker–North Quartz area contains multiple subsurface targets.

Baker is historically recognized as an epithermal gold–silver system with some porphyry affinities. Previous drilling also demonstrated that mineralization extends beyond the high-grade veins. In 2023, resampling of historical drill hole BK86-10 returned 100.3 metres grading 1.07 grams per tonne (“g/t”) gold, 0.10% copper and 4 g/t silver, including 37.4 metres grading 2.69 g/t gold and 0.19% copper. Reported drill intervals are core lengths. Estimated true widths are 40–60% of core length, and historical core recovery is unknown. Additional information is available in TDG’s August 15, 2023 news release.

The expanded soil footprint, multiple IP responses and historical broad mineralized drill intersections support evaluating Baker as a potentially larger hydrothermal system than indicated previously.

Black Gossan: Kilometre-Scale Subsurface Response

Preliminary DCIP modelling identifies a pronounced chargeability response over an approximately 2.1-kilometre horizontal extent in section, accompanied by relatively low resistivity.

The response is substantially larger than the historical surface occurrence and is associated with mapped alteration, anomalous soil geochemistry and magnetic contrasts. This combination supports the interpretation of a potentially extensive sulphide-bearing hydrothermal system.

Further interpretation will focus on identifying the most prospective near-surface portion of the response and distinguishing possible copper-bearing mineralization from a predominantly pyritic alteration envelope. The extent of the geophysical response does not necessarily represent a mineralized or economic deposit footprint.

Price–Trident: Coincident Geochemical and Geophysical Target

The Price–Trident area contains copper and gold soil enrichment associated with intrusive geology and a local magnetic feature. Preliminary modelling identifies separate shallow and deeper chargeability responses across an approximately 1.45-kilometre span in the broader Price–Trident sector.

The spatial relationship between the geochemistry, geology, magnetics and DCIP supports evaluating Price–Trident as an intrusive-related hydrothermal system with potential for near-surface copper–gold mineralization and associated epithermal mineralization.

The 2026 program has improved the definition of this target and provides a framework for locating the strongest convergence of surface geochemistry and subsurface geophysics.

Greater Shasta–Newberry (GSN): Evaluating Growth and Nearby Targets

In the GSN area, detailed soil sampling is improving coverage around the existing Shasta epithermal gold–silver mineral resource. The objective is to assess whether geochemical patterns, geological structures and geophysical responses identify opportunities to extend mineralization beyond the areas tested by historical and recent drilling.

Newberry remains an undrilled target situated along the same broader corridor as Shasta. Its multi-element soil signature, structural position and magnetic character support continued evaluation as a potential epithermal or intrusive-related target.

The integrated regional program provides, for the first time, a common dataset with which to assess Shasta, Newberry and the intervening ground. This is intended to help determine whether opportunities exist for resource growth at Shasta, nearby satellite mineralization or additional mineralizing centres along trend.

Emerging Regional Targets

Reconnaissance soil sampling has identified additional anomalous areas away from the principal historical showings. Follow-up work is evaluating these new targets based on their gold, copper and pathfinder-element signatures, geological setting, magnetic character and proximity to DCIP responses.

These areas remain at an early stage, but they expand the Company’s target inventory and demonstrate the benefit of assessing the entire corridor rather than limiting exploration to known occurrences.

Next Steps: Target Ranking and Selection

Remaining soil assays, infill sampling, geological mapping and final DCIP, resistivity, magnetic and magnetotelluric interpretations will be combined into a corridor-wide target-ranking framework.

Targets will be evaluated according to the strength, size and coherence of their geochemical response; interpreted depth and geometry of geophysical features; geological and structural setting; potential for near-surface mineralization; and the degree of agreement between independent datasets.

The objective is to develop a ranked portfolio from which to select targets for potential drill testing of:

  • extensions to known mineralized systems, including Baker and Shasta;
  • potential near-surface, gold-rich telescoped porphyry systems, using Aurora as a regional exploration model;
  • near-surface, bulk-tonnage epithermal gold–silver opportunities; and
  • potential new mineralizing centres identified through regional exploration.

TDG expects the completed program to provide the technical basis for selecting and sequencing follow-up ahead of the 2027 field season, with priority given to targets supported by the strongest combination of geological, geochemical and geophysical evidence.

Soil Sampling, Analytical Methods and Quality Assurance/Quality Control

Soil samples were collected predominantly from the B-horizon by trained field personnel using standardized procedures. Samples followed documented chain of custody between collection, processing and delivery to the analytical laboratory.

Samples were submitted to ALS Canada Ltd. (“ALS”) in Kamloops, British Columbia, for preparation and to ALS in Vancouver, British Columbia, for analysis.

Analysis utilized method AuME-ST43, comprising aqua-regia extraction of a 25-gram aliquot followed by inductively coupled plasma mass spectrometry and inductively coupled plasma atomic emission spectroscopy for gold and multiple elements. The method provides a lower gold detection limit of 0.1 parts per billion. Aqua regia provides a partial extraction, and reported results may not represent the total concentration of certain elements in the sample.

Quality assurance and quality control (“QA/QC”) are maintained internally by ALS through the use of certified reference materials, blanks and duplicates. TDG maintains an additional QA/QC program through the blind insertion of certified reference materials, blank samples and duplicate samples into the analytical sequence. If a QA/QC sample returns a result outside acceptable limits, an investigation is initiated and, where warranted, samples associated with the affected batch are reanalyzed.

Technical Disclosure

Soil anomalies identify areas of relative geochemical enrichment but do not establish the presence, dimensions, grade or continuity of mineralization. Geophysical anomalies may have multiple geological causes. Chargeability responses can reflect non-economic sulphides, including pyrite, and preliminary inversion geometries remain subject to refinement.

The exploration targets discussed in this release, other than the existing Shasta mineral resource, are conceptual in nature. There has been insufficient exploration to define mineral resources at these targets, and it is uncertain whether further exploration will result in the discovery of a mineral resource.

References to nearby deposits, discoveries and occurrences are provided solely for geological context and are not necessarily indicative of mineralization on TDG’s properties.

Qualified Person

Exploration activities at the Toodoggone Properties are overseen by Paul Geddes, P.Geo. In accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects, Paul Geddes, P.Geo., is the Qualified Person for the Toodoggone Projects and has written, validated and approved the technical and scientific content of this news release. The Company adheres to CIM Best Practices Guidelines in conducting, documenting, and reporting the exploration activities on its projects.

About TDG Gold Corp.

TDG Gold Corp. is a mineral exploration company focused on advancing its gold, silver and copper projects in British Columbia, Canada. The Company’s projects include Aurora West, the Shasta gold–silver deposit, the Baker Complex, the Mets prospect and the Anyox copper project.

TDG’s strategy is to create shareholder value through disciplined, capital-efficient exploration, technical evaluation, resource growth and advancement of its mineral projects.

ON BEHALF OF THE BOARD

Fletcher Morgan
Chief Executive Officer

For further information contact:
TDG Gold Corp.
Telephone: +1.604.536.2711
Email:info@tdggold.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information and Statements

This news release contains forward-looking information and forward-looking statements (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. Forward-looking statements relate to future events or future performance and reflect management’s current expectations, estimates, projections, assumptions and beliefs as of the date of this news release.

Forward-looking statements are often identified by words and expressions such as “continue”, “expect”, “is intended to”, “is designed to”, “objective”, “potential”, “evaluate”, “identify”, “prioritize”, “refine”, “select” and “support”, variants of these words and similar expressions, including the negative forms thereof, that certain events or conditions “may” or “will” occur.

Forward-looking statements in this news release include, without limitation, statements regarding: completion and results of the remaining 2026 soil sampling, DCIP surveys, receipt of outstanding assays, geological mapping and final geophysical interpretations; the refinement of anomaly boundaries and identification of priority near-surface targets; the integration and interpretation of geological, geochemical and geophysical information and whether such information will identify targets warranting follow-up or potential drill testing; the evaluation of Baker–North Quartz as a potentially larger hydrothermal system than previously indicated; the interpretation of Black Gossan as a potentially extensive sulphide-bearing hydrothermal system and the identification of its most prospective near-surface portion and differentiation of possible copper-bearing mineralization from predominantly pyritic alteration; the evaluation of Price–Trident as an intrusive-related hydrothermal system with potential for near-surface copper–gold mineralization and associated epithermal mineralization; the continued evaluation of Newberry as a potential epithermal or intrusive-related target; whether evaluation of Shasta, Newberry and the intervening ground will identify opportunities for mineral resource growth at Shasta, nearby satellite mineralization or additional mineralizing centres along trend; the evaluation of emerging regional targets; the development and results of the corridor-wide target-ranking framework; the identification, prioritization, ranking, selection and sequencing of targets for follow-up and potential drill testing, including extensions to known mineralized systems, potential near-surface gold-rich telescoped porphyry systems, near-surface bulk-tonnage epithermal gold–silver opportunities and potential new mineralizing centres; whether or not any of the targets identified and prioritized represent mineralizing systems of economic interest; whether the completed 2026 program will provide the technical basis for selecting and sequencing follow-up ahead of the 2027 field season; and the timing and execution of potential 2027 exploration, including drilling, and the results thereof.

Forward-looking statements are based on a number of assumptions, including but not limited to: the accuracy, reliability and representativeness of geological, geochemical and geophysical data, historical information and preliminary interpretations; the completion of remaining fieldwork, laboratory reporting and final geophysical interpretations in time to inform target evaluation and selection ahead of the 2027 field season; the ability of such information to support target evaluation, refinement, ranking and selection; the availability of financing, personnel, contractors, equipment and laboratory services; the receipt and maintenance of required approvals and permits; and favourable site access, weather and operating conditions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, without limitation: the risk that remaining fieldwork, outstanding assays or final geophysical interpretations may not support current interpretations or identify targets warranting follow-up; the risk that geological, geochemical or geophysical anomalies may have non-economic causes, including non-economic sulphides such as pyrite; uncertainty as to whether identified anomalies represent mineralized systems or whether further exploration will identify extensions to known mineralized systems, resource growth, satellite mineralization or additional mineralizing centres; the risk that further evaluation may not support current interpretations of Baker–North Quartz, Black Gossan, Price–Trident, Newberry or other regional targets; the risk that target rankings, priorities and interpretations may change as additional information becomes available; the risk that identified or selected targets may not warrant drill testing or may not be drilled; delays, modifications or cancellation of follow-up exploration or potential drilling; the availability of financing; environmental, permitting, regulatory, access, weather and operating risks; and the other risks disclosed in the Company’s public disclosure documents available under its profile on SEDAR+.

The exploration targets discussed in this news release, other than the existing Shasta mineral resource, are conceptual in nature. Geological, geochemical and geophysical anomalies do not establish the presence, dimensions, grade or continuity of mineralization and may have non-economic causes. There has been insufficient exploration to define mineral resources at these targets, and it is uncertain whether further exploration will result in the discovery of a mineral resource. The reported dimensions describe exploration anomalies or groupings of anomalies, not established mineralized dimensions. Geophysical responses can have non-economic causes, including pyrite, and the interpretations remain preliminary.

Although the Company believes the assumptions and expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such statements will prove to be accurate. Readers should not place undue reliance on forward-looking statements. Actual results may differ materially from those anticipated in such statements.

The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligation to update such statements except as required by applicable securities laws.

Figure 1: 2026 Currently Defined Gold and Copper Soil Anomalies.

Figure 1 - Sept 23, 2026 NR

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7569cc7d-0fe5-4da4-a2e7-6087d4903549

Esper Joins LT350 Board to Advance the Next Generation of Secure, Distributed, AI Infrastructure for Defense and Critical Infrastructure Resilience

BOULDER, Colo., Sept. 23, 2026 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ: AUUD) (“Auddia” or the “Company”), an AI-first technology company pursuing a merger that, if completed, would form McCarthy Finney, an AI-native operating company, today announced the appointment of former U.S. Secretary of Defense Mark T. Esper to the LT350 Board of Directors. The appointment represents a pivotal step in LT350’s development as a national security aligned technology company advancing resilient, edge based AI compute for critical government and civil infrastructure. Esper’s leadership and experience strengthens LT350’s strategic perspective as the company advances toward potential commercial and defense deployments.

LT350 is one of three businesses that would combine with Auddia to form McCarthy Finney if Auddia’s announced business combination with Thramann Holdings, LLC (“Thramann Holdings”) is completed.

Secretary Esper’s Perspective on LT350’s Role

“Secure, distributed compute is becoming foundational to America’s military readiness, economic competitiveness, and critical-infrastructure resilience,” said the Honorable Mark T. Esper, PhD, 27th Secretary of Defense. “LT350’s approach to rapidly deployable, community compatible AI infrastructure reflects the kind of innovation our nation needs to strengthen resilience, reduce vulnerabilities, and expand capacity at the edge. I look forward to supporting LT350 as it advances this next generation of infrastructure.”

Why It Matters

LT350’s parking lot canopy based AI datacenter architecture is designed to support emerging federal and allied priorities for distributed secure compute at the edge and the energy resilience required to optimize continuity of critical operations. Esper’s appointment positions LT350 to pursue strategic engagement across defense modernization, critical infrastructure resilience, and energy grid reinforcement while maintaining a clear focus on commercial deployment.

Strengthening LT350’s National Security Positioning

LT350’s modular canopy based AI compute platform is engineered to deliver secure, networked, distributed AI processing across critical infrastructure networks. Esper’s experience leading the Department of Defense and addressing national security and infrastructure modernization priorities provides LT350 with critical perspective on:

  • Defense grade infrastructure resilience
  • AI-enabled situational awareness and edge compute deployment
  • Public-private collaboration in critical infrastructure modernization
  • Strategic alignment with emerging U.S. and allied initiatives in distributed inference, autonomous systems, and resilient energy infrastructure

“Mark’s leadership and national security perspective are invaluable as LT350 scales its platform for both commercial and defense applications,” said Jeff Thramann, founder and CEO of Auddia and LT350. “His appointment to the LT350 Board reinforces LT350’s mission to build infrastructure that strengthens resilience across multiple sectors critical to enhancing national security and competitiveness.”

Looking Ahead

LT350 is advancing plans for pilot deployments of its canopy based datacenter infrastructure and intends to pursue initial commercial and defense partnerships following the merger closing. Esper’s appointment to the LT350 Board strengthens LT350’s ability to align its strategy with national security priorities while supporting commercial adoption.

If the pending merger with Thramann Holdings is completed, investors in Auddia will gain exposure to LT350 through McCarthy Finney Inc. (MCFN), and LT350 will operate as a wholly owned subsidiary of MCFN following closing.

About the Merger to form McCarthy Finney (MCFN)

Auddia entered into a definitive merger agreement with Thramann Holdings, LLC on February 17, 2026. If completed, the transaction would combine Auddia with three early-stage, AI-native operating companies wholly owned by Thramann Holdings: LT350, Influence Healthcare, and Voyex. The combined company would be renamed McCarthy Finney Inc. and is expected to trade under the ticker MCFN, subject to applicable approvals and listing requirements. McCarthy Finney would operate as an AI holding company supporting LT350, Influence Healthcare, Voyex, and Auddia with AI and Web3 capabilities.

  • LT350 is a distributed AI datacenter company with 14 issued patents and 3 pending patent applications covering its proprietary solar parking lot canopy infrastructure platform. The platform integrates modular battery storage and GPU cartridges into the canopy ceiling to convert the airspace of underutilized parking areas into distributed AI datacenters. LT350 aims to build a secure, low latency, cost effective, and rapidly deployable edge network while supporting local power infrastructure resilience.
  • Influence Healthcare is a healthtech company leveraging AI, blockchain, and vertical integration to empower surgeons to drive adoption of value based care (VBC) to the surgical specialties. The Company’s mission is to leverage technology and value based enterprises (VBEs) to build an alternative healthcare system that minimizes the corporate practice of medicine, eliminates administrative waste, and enhances the autonomy and pay of health care providers to empower them to improve quality and return the patient physician relationship to the center of medicine.
  • Voyex is a travel services platform that leverages agentic AI, an integrated fintech platform, and utilization of charter and private jet aircraft to significantly improve the travel experience. The Company aims to alleviate the leading pain points for travelers of lengthy flight delays and cancellations.

About Auddia Inc.

Auddia, through its proprietary AI platform for audio identification and classification, is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. Auddia’s Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Auddia’s flagship audio superapp, called faidr, delivers multiple industry firsts, including:

  • Ad-free listening on any AM/FM radio station
  • Content skipping across any AM/FM station
  • One-touch skipping of entire podcast ad breaks
  • Integrated artist discovery experiences

For more information, visit www.auddia.com.

Cautionary Note on Forward-Looking Statements

Certain statements in this communication, other than purely historical information, may constitute “forward-looking statements” within the meaning of the federal securities laws, including for purposes of the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995, concerning Auddia, Thramann Holdings, and the proposed merger between Auddia and Thramann Holdings (the “Proposed Transaction”) and other matters. These forward-looking statements include, but are not limited to, express or implied statements relating to Auddia’s and Thramann Holdings’ management expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding: the structure, timing and completion of the proposed merger by and between Auddia and Thramann Holdings, and the expected effects, perceived benefits or opportunities of the Proposed Transaction; the combined company’s listing on Nasdaq after the closing of the Proposed Transaction; expectations regarding the structure, timing and completion of the financing needed to close the Proposed Transaction, including investment amounts from investors, timing of closing of the Proposed Transaction, expected proceed, expectations regarding the use of proceeds, and impact on ownership structure; the anticipated timing of the closing; the expected executive officers and directors of the combined company; each company’s and the combined company’s expected cash position at the closing and cash runway of the combined company following the proposed merger and any additional financing; the future operations of the combined company, including research and development activities; the nature, strategy and focus of the combined company; the development and commercial potential and potential benefits of any products and services of the combined company; the cash balance of the combined entity at closing; expectations related to the anticipated timing of the closing of the Proposed Transaction (the “Closing”); the expectations regarding the ownership structure of the combined company; the expected trading of the combined company’s stock on Nasdaq under the ticker symbol “MCFN” after the Closing; and other statements that are not historical fact.

All statements other than statements of historical fact contained in this communication are forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “opportunity,” “potential,” “milestones,” “pipeline,” “can,” “goal,” “strategy,” “target,” “anticipate,” “achieve,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “plan,” “possible,” “project,” “should,” “will,” “would” and similar expressions (including the negatives of these terms or variations of them) may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are made based on current expectations, estimates, forecasts, and projections, as well as the beliefs and assumptions of management, concerning future developments and their potential effects. There can be no assurance that future developments affecting Auddia, Thramann Holdings, or the Proposed Transaction will be those that have been anticipated.

These forward-looking statements involve a number of risks and uncertainties, some of which are beyond Auddia’s or Thramann Holdings’ control, or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that the conditions to the Closing or consummation of the Proposed Transaction are not satisfied, including the failure to timely obtain approval of the proposed merger from Auddia’s stockholders the risk that the required financing is not obtained in a timely manner, if at all; uncertainties as to the timing of the consummation of the Proposed Transaction; risks related to Auddia’s continued listing on Nasdaq until closing of the Proposed Transaction and the combined company’s ability to remain listed following the Closing; uncertainties regarding the impact any delay in the Closing would have on the anticipated cash resources of the combined company, and other events and unanticipated spending and costs that could reduce the combined company’s cash resources; the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement; the effect of the announcement or pendency of the merger on Auddia’s or Thramann Holdings’ business relationships, operating results and business generally; costs related to the merger; the risk that as a result of adjustments to the exchange ratio, Auddia’s or Thramann Holdings’ stockholders could own more or less of the combined company than is currently anticipated; risks related to the market price of Auddia’s common stock relative to the value suggested by the exchange ratio; risks related to the inability of the combined company to obtain sufficient additional capital to continue to advance the development of its products and services; costs of the Proposed Transaction and unexpected costs, charges or expenses resulting from the Proposed Transaction; potential adverse reactions or changes to business relationships, operating results, and business generally, resulting from the announcement or completion of the Proposed Transaction.

Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in periodic filings with the SEC, including the factors described in the section titled “Risk Factors” in Auddia’s Annual Report on Form 10-K for the year ended December 31, 2025, which was originally filed with the SEC on March 6, 2026, subsequent Quarterly Reports on Form 10-Q filed with the SEC, and in other filings that Auddia makes and will make with the SEC in connection with the Proposed Transaction, including the Form S-4 and Proxy Statement described below, as well as discussions of potential risks, uncertainties, and other important factors included in other filings by Auddia from time to time. Should one or more of these risks or uncertainties materialize, or should any of Auddia’s or Thramann Holdings’ assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Neither Auddia nor Thramann Holdings undertakes or accepts any duty to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as required by law. This communication does not purport to summarize all of the conditions, risks and other attributes of an investment in Auddia or Thramann Holdings.

No Offer or Solicitation

This communication and the information contained herein is not intended to and does not constitute (i) a solicitation of a proxy, consent or approval with respect to any securities or in respect of the proposed transaction or (ii) an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law, or an exemption therefrom. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, the public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.

NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR DETERMINED IF THIS COMMUNICATION IS TRUTHFUL OR COMPLETE.

Important Additional Information about the Proposed Transaction Will be Filed with the SEC

This communication relates to the proposed merger involving Auddia and Thramann Holdings and may be deemed to be solicitation material in respect of the proposed merger. In connection with the proposed Transaction, Auddia intends to file relevant materials with the SEC, including a registration statement on Form S-4 (the “Form S-4”) that will contain a proxy statement (the “Proxy Statement”) and prospectus. This communication is not a substitute for the Form S-4, the Proxy Statement or for any other document that Auddia may file with the SEC and/or send to Auddia’s stockholders in connection with the proposed merger. AUDDIA URGES, BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS TO READ THE FORM S-4, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AUDDIA, THRAMANN HOLDINGS, THE PROPOSED TRANSACTION AND RELATED MATTERS.

Investors and stockholders will be able to obtain free copies of the Form S-4, the Proxy Statement and other documents filed by Auddia with the SEC (when they become available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed by Auddia with the SEC will also be available free of charge on Auddia’s website at www.auddia.com or by contacting Auddia Investor Relations at investors.auddiainc.com/contact. In addition, investors and stockholders should note that Auddia communicates with investors and the public through its investor-relations website at investors.auddiainc.com.

Participants in the Solicitation

Auddia, Thramann Holdings, and their respective directors and certain of their executive officers and other members of management may be deemed to be participants in the solicitation of proxies from Auddia’s stockholders in connection with the proposed transaction under the rules of the SEC. Information about Auddia’s directors and executive officers, including a description of their interests in Auddia, is included in Auddia’s most recent Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on March 6, 2026. Additional information regarding the persons who may be deemed participants in the proxy solicitations, including about the directors and executive officers of Thramann Holdings, and a description of their direct and indirect interests, by security holdings or otherwise, will also be included in the Form S-4, the Proxy Statement and other relevant materials to be filed with the SEC when they become available. These documents can be obtained free of charge from the sources indicated above.

Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
www.pcgadvisory.com

  • Immunovant’s proof-of-concept study of IMVT-1402 (imeroprubart) in cutaneous lupus erythematosus (CLE) did not achieve statistical significance on the primary endpoint of Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity (CLASI-A) percent change from baseline at Week 12
  • Positive trends were observed on multiple endpoints, with deeper IgG reductions resulting in improved clinical outcomes, but the study did not meet Immunovant’s internal bar to continue development of IMVT-1402 in CLE
  • IMVT-1402 demonstrated a favorable safety and tolerability profile, consistent with prior studies
  • All other clinical development timelines remain on track

DURHAM, N.C., Sept. 23, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq: IMVT) today announced topline results from Period 1 of its proof-of-concept trial evaluating IMVT-1402 (imeroprubart) for the treatment of cutaneous lupus erythematosus (CLE).

The study did not achieve statistical significance on its primary endpoint of percent change from baseline in the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity (CLASI-A) score at Week 12. Numerical trends favoring IMVT-1402 over placebo were observed across multiple endpoints, and patients who achieved deeper IgG reductions from baseline were more likely to achieve improved clinical responses. However, due to the competitive landscape and the clinical results observed, Immunovant plans to stop development in CLE.

“On behalf of everyone at Immunovant, I want to thank the patients living with CLE who volunteered for this study and the investigators and clinical site teams who conducted it with such care. Their contributions advance our understanding of FcRn inhibition in autoimmune disease and will inform our work going forward,” said Eric Venker, M.D., Pharm.D., Chief Executive Officer of Immunovant.

Immunovant remains focused on rapidly advancing the clinical development of IMVT-1402 across multiple autoimmune diseases with significant unmet need, including Graves’ disease, difficult-to-treat rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and Sjogren’s disease.

About the Proof-of-Concept Study of IMVT-1402 in CLE
The proof-of-concept clinical study (NCT06980805) of IMVT-1402 (imeroprubart) in CLE is a randomized, double-blind, placebo-controlled, global trial that assessed the safety and efficacy of IMVT-1402 in adult patients with CLE. The study enrolled 57 patients. In Period 1, patients were randomized to IMVT-1402 vs. placebo for a 12-week treatment period. The primary endpoint was the percent change from Period 1 baseline in CLASI-A score at Week 12.

About Immunovant
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com.

Forward-Looking Statements
This press release contains forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as “can,” “may,” “might,” “will,” “would,” “should,” “expect,” “believe,” “estimate,” “design,” “plan,” “intend,” and other similar expressions are intended to identify forward-looking statements. Such forward-looking statements include statements regarding Immunovant’s plans and progress towards developing IMVT-1402 across a broad range of indications. All forward-looking statements are based on estimates and assumptions by Immunovant’s management that, although Immunovant believes to be reasonable, are inherently uncertain. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that Immunovant expected. Such risks and uncertainties include, among others: Immunovant may not be able to protect or enforce its intellectual property rights; initial results or other preliminary analyses or results of early clinical trials may not be predictive final trial results or of the results of later clinical trials; the timing and availability of data from clinical trials; the timing of discussions with regulatory agencies, as well as regulatory submissions and potential approvals; the continued development of Immunovant’s product candidates, including the number and timing of the commencement of additional clinical trials; Immunovant’s scientific approach, clinical trial design, indication selection, regulatory strategy, and general development progress; future clinical trials may not confirm any safety, potency, or other product characteristics described or assumed in this press release; any product candidate that Immunovant develops may not progress through clinical development or receive required regulatory approvals within expected timelines or at all; Immunovant’s product candidates may not be beneficial to patients, or even if approved by regulatory authorities, successfully commercialized; the potential impact of global factors, such as international trade tariffs, geopolitical tensions, and adverse macroeconomic conditions on Immunovant’s business operations and supply chain, including its clinical development plans and timelines; Immunovant’s business is heavily dependent on the successful development, regulatory approval, and commercialization of IMVT-1402; Immunovant is at various stages of clinical development for IMVT-1402; and Immunovant will require additional capital to fund its operations and advance IMVT-1402 through clinical development. These and other risks and uncertainties are more fully described in Immunovant’s periodic and other reports filed with the Securities and Exchange Commission (SEC), including in the section titled “Risk Factors” in Immunovant’s Annual Report on Form 10-K filed with the SEC on May 20, 2026, and Immunovant’s subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Immunovant undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contacts:
Investors
Keyur Parekh
keyur.parekh@roivant.com
Media
Stephanie Lee
stephanie.lee@roivant.com

TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce that the Company has qualified to for trading on the OTCQX® Best Market. Talisker shares will begin trading today on OTCQX under the symbol “TSKFF”.

The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

Trading in non-U.S. North American securities on OTC Markets reached $23.4 billion in the second quarter of 2026, representing an 88.25% increase over Q2 2025. OTC Markets recorded $453.34 billion in total dollar volume in the first half of the year. Canada ranked among the top home markets by trading volume during the quarter, highlighting sustained U.S. investor demand for internationally listed names.

Terry Harbort, CEO of Talisker stated, “We are pleased to have re-qualified for trading on the OTCQX Market which we anticipate will provide Talisker with wider visibility to the U.S. investment community.”

For further information, please contact:

Lindsay Dunlop
Vice President, Investor Relations
lindsay.dunlop@taliskerresources.com
+1 647 274 8975

About Talisker Resources Ltd.

Talisker (taliskerresources.com) is a junior resource company involved in the exploration and development of gold projects in British Columbia, Canada. Talisker’s flagship asset is the high-grade, fully permitted Bralorne Gold Project where the Company is producing at the Mustang Mine. Talisker projects also include the Ladner Gold Project, an historic high-grade gold mine near Hope, British Columbia, with significant exploration potential, and the Spences Bridge Project, where the Company has a significant landholding in the emerging Spences Bridge Gold Belt, as well as several other early-stage Greenfields projects.

Caution Regarding Forward Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Talisker’s current belief or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information relating to, among other things, the benefits of listing on the OTCQX Market. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to Talisker. Although such statements are based on reasonable assumptions of Talisker’s management, there can be no assurance that any conclusions or forecasts will prove to be accurate. The forward-looking information contained in this release is made as of the date hereof, and Talisker is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to report results from 100 drill holes from its now-complete Phase 2 drill program at the 100%-owned Pardo “River of Gold” Project, located 65 km northeast of Sudbury, Ontario. Results from an additional 89 drill holes remain pending (Figure 1).

The latest drilling continues to strengthen the Company’s view of Pardo as a large, shallow gold system with multiple stacked gold-bearing layers and more than one potential development opportunity.

Drilling has identified several areas of higher-grade gold within the Main Conglomerate Layer (“Main Layer” or “MiBC”), highlighted by 4.96 g/t gold over 2.09 m, including 30.04 g/t gold over 0.33 m in PD-26-348, beginning only 2.72 m from surface.

Importantly, these higher-grade results are being returned from several different areas demonstrating continuity. The Main Layer also contains broader lower-grade mineralization between and around higher-grade intervals, showing that the MiBC itself may have potential beyond the higher-grade material being targeted for direct ship ore (“DSO”) development.

Gold mineralization also occurs within the Matinenda Conglomerate (“MaC”), Upper Conglomerate (“MiPC”) and Upper Sandstone (“MiBS”) layers. Together, the MiBC, MaC, MiPC and MiBS form a shallow, stacked system of multiple gold-bearing layers at Pardo (Figure 2). The Company is advancing the shallow, higher-grade portions of the Main Layer as part of its DSO development strategy, while larger volumes of mineralized material, including lower-grade mineralization across all four layers, are defining a broader bulk-tonnage opportunity.

HIGHLIGHTS

  • Multiple areas of shallow, higher-grade Main Layer mineralization continue to demonstrate continuity within the near-surface DSO area, where the Main Layer occurs within approximately 15 metres of surface.
  • Main Layer drilling highlights include:
    • 4.96 g/t gold over 2.09 m, including 30.04 g/t gold over 0.33 m, beginning only 2.72 m from surface in PD-26-348.
    • 2.48 g/t gold over 3.71 m, including 8.44 g/t gold over 0.97 m and 12.61 g/t gold over 0.50 m in PD-26-332.
    • 1.05 g/t gold over 8.25 m, including 3.01 g/t gold over 2.55 m and 9.49 g/t gold over 0.44 m in PD-26-324.
    • 2.03 g/t gold over 2.42 m, including 4.02 g/t gold over 1.00 m and 5.74 g/t gold over 0.50 m in PD-26-333.
    • 1.38 g/t gold over 4.78 m, including 2.60 g/t gold over 2.35 m and 6.27 g/t gold over 0.43 m in PD-26-359.
    • 2.00 g/t gold over 2.28 m, including 4.00 g/t gold over 1.00 m and 9.31 g/t gold over 0.30 m in PD-26-379.
  • Broad lower-grade gold mineralization occurs within the Main Layer itself and within the MaC, MiPC and MiBS layers, showing that gold mineralization at Pardo extends well beyond the higher-grade areas of the Main Layer.
  • Examples of broader lower-grade mineralization include:
    • 0.54 g/t gold over 3.75 m in the MiBC, including 2.67 g/t gold over 0.43 m, in PD-26-367.
    • 0.23 g/t gold over 5.76 m in the MiBC, including 1.08 g/t gold over 0.50 m, in PD-26-399.
    • 0.81 g/t gold over 2.95 m in the MaC, including 1.33 g/t gold over 1.42 m, in PD-26-305.
    • 0.48 g/t gold over 4.88 m in the MaC, including 0.70 g/t gold over 2.58 m, in PD-26-306.
    • 0.50 g/t gold over 5.92 m in the MiPC, including 1.29 g/t gold over 1.30 m, in PD-26-369.
    • 0.27 g/t gold over 6.71 m in the MiPC and 0.43 g/t gold over 1.70 m in the MiBS in PD-26-375.
    • 0.72 g/t gold over 1.84 m in the MiBS in PD-26-316.
  • Gold mineralization also occurs within the Matinenda Conglomerate (“MaC”), Upper Conglomerate (“MiPC”) and Upper Sandstone (“MiBS”) layers. Together, the MiBC, MaC, MiPC and MiBS form a shallow, stacked system of multiple gold-bearing layers at Pardo (Figure 2). The Company believes the higher-grade portions of the Main Layer could support its DSO development strategy, while the broader lower-grade mineralization across all four layers provides additional bulk-tonnage potential. Heap leaching is being evaluated as one potential lower-cost processing option that could further improve the economics of this material.
  • Results from an additional 89 drill holes remain pending, with Phase 3 drilling planned to begin in mid-October and the maiden mineral resource estimate planned for Q4 2026.

Wesley Whymark, CEO & Director, comments: “These results continue to build our confidence in Pardo. The Main Layer remains the foundation of our near-term development strategy, and we are seeing strong gold grades across several different areas. PD-26-348 is a great example, returning nearly 5 g/t gold over more than two metres starting less than three metres below surface.”

“What is becoming equally interesting is the amount of lower-grade gold mineralization throughout the system. The Main Layer itself contains broader lower-grade intervals in addition to the higher-grade zones, while the MaC, MiPC and MiBS layers are also returning broad gold-bearing intervals. This means we need to look at Pardo as more than just a single high-grade layer.”

“Our DSO area is defined by how close the Main Layer is to surface, not by where the higher-grade gold ends. Strong Main Layer grades continue below and outside the DSO area, while broader lower-grade mineralization across several layers is building a separate bulk-tonnage opportunity. With 89 drill results pending, Phase 3 drilling starting in mid-October, the maiden resource estimate underway, there is still a lot more to come from Pardo.”

PHASE 2 DRILLING UPDATE

Inventus has now completed its Phase 2 drill program at Pardo. The program targeted the shallow and laterally extensive Main Layer, together with the MiPC, MiBS and MaC layers.

Results from 100 holes are reported in this release (see Tables 1 and 2), with assays from another 89 holes pending.

The latest drilling continues to identify several areas of strong Main Layer mineralization across the property. Hole PD-26-348 returned 4.96 g/t gold over 2.09 m from only 2.72 m depth, including 30.04 g/t gold over 0.33 m. Nearby drilling returned 1.71 g/t gold over 1.43 m in PD-26-345, while PD-26-333 returned 2.03 g/t gold over 2.42 m, including 4.02 g/t gold over 1.00 m.

Another area of strong mineralization is highlighted by PD-26-332, which returned 2.48 g/t gold over 3.71 m, including 8.44 g/t gold over 0.97 m and 12.61 g/t gold over 0.50 m.

Additional Main Layer results include 1.88 g/t gold over 1.42 m in PD-26-358, 1.38 g/t gold over 4.78 m in PD-26-359, and 1.64 g/t gold over 1.55 m in PD-26-366.

Farther north, drilling returned 2.00 g/t gold over 2.28 m in PD-26-379 and 2.34 g/t gold over 1.44 m in PD-26-381.

The drilling also shows that the Main Layer contains a wider range of gold grades than the higher-grade highlights alone suggest. Lower-grade MiBC intervals can extend for several metres, including 0.54 g/t gold over 3.75 m in PD-26-367 and 0.40 g/t gold over 4.28 m in PD-26-337. This broader mineralized material adds to the bulk-tonnage potential at Pardo.

The importance of these results is their distribution. Higher-grade Main Layer mineralization is being intersected in several different parts of the drilled area, supporting the Company’s interpretation of a laterally extensive mineralized layer containing multiple areas of higher-grade gold mineralization. This drilling is helping Inventus better understand the full extent and grade distribution of the gold-bearing layers improving confidence ahead of the planned maiden mineral resource estimate. With Phase 2 drilling now complete, Phase 3 drilling is planned to begin in mid-October 2026.

BROAD LOWER-GRADE MINERALIZATION AND BULK-TONNAGE POTENTIAL

One of the more important developments from Phase 2 drilling is the amount of lower-grade gold mineralization being identified throughout the Pardo system.

This mineralization is not limited to the layers above and below the Main Layer. The MiBC itself contains both higher-grade zones and broader lower-grade intervals. This is important because it increases the amount of mineralized material that could potentially be considered in a larger-scale development scenario, beyond the shallow part of higher-grade material currently being advanced for DSO development.

The MaC layer also continues to return encouraging results, including 0.81 g/t gold over 2.95 m in PD-26-305, including 1.33 g/t gold over 1.42 m, and 0.48 g/t gold over 4.88 m in PD-26-306, including 0.70 g/t gold over 2.58 m.

These results build on previously reported drilling that demonstrated the MaC can also contain higher-grade gold (see news release July 6, 2026). The MaC therefore has potential both as a source of broader lower-grade mineralization and as another layer capable of hosting higher-grade gold.

The MiPC layer is particularly interesting because of its thickness and shallow position. Recent results include 0.50 g/t gold over 5.92 m in PD-26-369, including 1.29 g/t gold over 1.30 m, 0.40 g/t gold over 4.63 m in PD-26-368, 0.32 g/t gold over 4.67 m in PD-26-320, and 0.27 g/t gold over 6.71 m in PD-26-375. Other MiPC intersections have been observed to exceed seven and eight metres in thickness.

The MiBS layer has also returned gold mineralization, including 0.72 g/t gold over 1.84 m in PD-26-316, 0.43 g/t gold over 1.70 m in PD-26-375, and 0.34 g/t gold over 3.04 m in PD-26-429. Together, the results demonstrate that Pardo is not simply a single gold-bearing layer. It is a shallow, stacked system where gold occurs across several layers and across a range of grades.

The broader lower-grade mineralization within the MiBC, MaC, MiPC and MiBS layers is defining a significant bulk-tonnage opportunity at Pardo that is expected to be further outlined in the upcoming maiden mineral resource estimate. The shallow, flat-lying geometry of these stacked gold-bearing layers is particularly important because they occur close together, near surface and could potentially be accessed within the same development area.

Earlier heap-leach test work at Pardo returned very encouraging gold recoveries (see news release August 6, 2026), and the Company is continuing to evaluate heap leaching as a potential lower-cost processing method for this material. If further testing continues to support these results, heap leaching could improve the economics of a future bulk-tonnage operation, but the bulk-tonnage potential itself is not dependent on this processing method. Together, the shallow higher-grade DSO potential of the Main Layer and the broader bulk-tonnage opportunity across multiple gold-bearing layers continue to expand the scale and development potential of Pardo.

NEXT STEPS

  • Complete and report assays from the 89 drill holes currently pending.
  • Incorporate Phase 2 drilling results into the geological model for the planned maiden mineral resource estimate.
  • Commence Phase 3 drilling in mid-October 2026 to further expand the footprint of gold mineralization.
  • Advance the shallow higher-grade portions of the Main Layer including the ore sorting test work and incorporated into a preliminary economic assessment for the Company’s planned DSO development strategy.
  • Continue metallurgical test work on the lower-grade mineralization from the MiBC, MaC, MiPC and MiBS layers including heap leaching.
  • Evaluate the potential for the stacked gold-bearing layers to increase the overall scale and development strategy at Pardo.

For further information visit www.inventusmining.com, or contact:

Wesley Whymark
CEO & Director
Inventus Mining Corp.
E-mail: wesley@inventusmining.com
Phone: 705-822-3005

Social Media Accounts

X: https://x.com/InventusMining
LinkedIn: https://ca.linkedin.com/company/inventus-mining
YouTube: https://www.youtube.com/@inventusmining
Facebook: https://www.facebook.com/profile.php?id=61587627317147

Phase 2 drill map showing reported assays in red and pending assays in green.
Figure 1. Plan map showing Phase 2 drill holes with reported assays in red and holes with pending assays in green.

Geological section showing Pardo’s four shallow, stacked gold-bearing layers.
Figure 2. Simplified geological section illustrating the shallow, stacked gold-bearing layers at the Pardo “River of Gold” Project, including the MiPC, MiBS, Main Layer (MiBC) and Matinenda Layer (MaC).

Table 1. Recent Phase 2 Drilling Assay Highlights.

Drill Hole From
(Metres)
To
(Metres)
Zone1 Interval2
(Metres)
Gold Grade
(g/t)
PD-26-301 25.86 31.07 MiBC-MaC 5.21 0.43
PD-26-302 30.50 32.51 MiBC-MaC 2.01 0.94
Including 30.95 31.25 MiBC 0.30 4.35
PD-26-304 28.74 32.34 MaC 3.60 0.51
Including 30.96 31.34 MaC 0.38 1.20
PD-26-305 30.47 33.42 MaC 2.95 0.81
Including 32.00 33.42 MaC 1.42 1.33
Including 32.42 32.92 MaC 0.50 2.58
PD-26-306 28.50 33.38 MaC 4.88 0.48
Including 29.92 32.50 MaC 2.58 0.70
PD-26-308 2.67 9.89 MiPC 7.22 0.20
and 12.24 14.68 MiBS 2.44 0.20
PD-26-309 3.63 7.78 MiPC 4.15 0.25
PD-26-312 0.64 4.25 MiPC 3.61 0.35
PD-26-313 0.23 5.03 MiPC 4.80 0.23
PD-26-314 0.68 6.31 MiPC 5.63 0.24
PD-26-315 0.31 8.76 MiPC 8.45 0.16
and 13.45 14.88 MiBS 1.43 0.37
and 25.70 28.70 MiBC 3.00 0.28
and 35.23 37.64 MiBC 2.41 0.23
PD-26-316 0.15 7.43 MiPC 7.28 0.20
and 19.00 20.84 MiBS 1.84 0.72
and 25.03 29.24 MiBC 4.21 0.32
and 31.75 34.22 MiBC 2.47 0.22
PD-26-317 0.50 2.37 MiPC 1.87 0.24
and 29.76 32.21 MiBC 2.45 0.32
and 37.10 40.81 MiBC 3.71 0.46
Including 39.50 40.50 MiBC 1.00 1.21
PD-26-318 0.75 6.83 MiPC 6.08 0.23
and 25.61 30.50 MiBC 4.89 0.21
and 37.86 41.09 MiBC 3.23 0.55
Including 38.82 39.24 MiBC 0.42 1.47
PD-26-319 0.50 8.50 MiPC 8.00 0.23
and 31.61 43.10 MiBC 11.49 0.23
PD-26-320 0.66 5.33 MiPC 4.67 0.32
and 37.90 40.73 MiBC 2.83 1.23
Including 39.38 40.73 MiBC 1.35 2.44
Including 40.23 40.73 MiBC 0.50 5.21
PD-26-322 5.40 10.87 MiPC 5.47 0.32
and 15.78 17.39 MiBC 1.61 1.60
Including 16.23 17.00 MiBC 0.77 2.62
PD-26-323 9.62 14.74 MiPC 5.12 0.26
and 22.25 25.56 MiBC 3.31 0.29
PD-26-324 14.30 22.55 MiBC 8.25 1.05
Including 20.00 22.55 MiBC 2.55 3.01
Including 20.93 21.37 MiBC 0.44 9.49
PD-26-325 14.52 19.55 MiBC 5.03 0.30
PD-26-326 6.70 10.08 MiBC 3.38 0.76
Including 8.62 10.08 MiBC 1.46 1.26
Including 9.72 10.08 MiBC 0.36 3.26
PD-26-327 7.65 12.26 MiBC 4.61 0.63
Including 10.50 12.26 MiBC 1.76 1.43
Including 11.00 11.43 MiBC 0.43 3.83
PD-26-328 9.76 12.15 MiBC 2.39 1.02
Including 11.16 11.80 MiBC 0.64 2.71
PD-26-329 6.89 9.33 MiBC 2.44 0.70
Including 8.89 9.33 MiBC 0.44 1.34
PD-26-332 7.95 11.66 MiBC 3.71 2.48
Including 9.24 10.21 MiBC 0.97 8.44
Including 9.24 9.74 MiBC 0.50 12.61
PD-26-333 4.00 6.42 MiBC 2.42 2.03
Including 4.93 5.93 MiBC 1.00 4.02
Including 4.93 5.43 MiBC 0.50 5.74
PD-26-335 5.40 6.49 MiBC 1.09 1.86
PD-26-337 9.30 12.88 MiPC 3.58 0.25
and 29.00 33.28 MiBC 4.28 0.40
Including 29.50 30.00 MiBC 0.50 1.29
PD-26-338 6.00 8.54 MiPC 2.54 0.33
and 30.12 34.10 MiBC 3.98 0.30
PD-26-339 28.90 32.32 MiBC 3.42 0.40
Including 31.88 32.32 MiBC 0.44 1.85
PD-26-342 3.03 4.96 MiPC 1.93 0.34
PD-26-345 3.35 4.78 MiBC 1.43 1.71
Including 3.35 3.85 MiBC 0.50 3.56
PD-26-348 2.72 4.81 MiBC 2.09 4.96
Including 2.72 3.05 MiBC 0.33 30.04
PD-26-349 1.75 2.68 MiBC 0.93 0.95
PD-26-354 0.00 0.75 MiBC 0.75 1.38
PD-26-355 1.00 1.75 MiBC 0.75 2.12
PD-26-356 0.71 4.95 MiBC 4.24 1.02
Including 2.95 4.44 MiBC 1.49 2.34
Including 3.31 3.61 MiBC 0.30 6.13
PD-26-357 1.25 3.67 MiBC 2.42 0.41
PD-26-358 8.70 10.12 MiBC 1.42 1.88
Including 9.33 10.12 MiBC 0.79 3.14
Including 9.73 10.12 MiBC 0.39 4.96
PD-26-359 5.48 10.26 MiBC 4.78 1.38
Including 7.07 9.42 MiBC 2.35 2.60
Including 7.07 7.50 MiBC 0.43 6.27
PD-26-362 11.60 13.23 MiBC 1.63 0.51
Including 12.45 12.76 MiBC 0.31 1.73
PD-26-363 9.75 12.32 MiBC 2.57 1.08
Including 10.15 10.50 MiBC 0.35 3.57
PD-26-364 9.29 12.19 MiBC 2.90 0.41
PD-26-365 2.97 4.65 MiPC 1.68 0.26
and 12.95 14.76 MiBC 1.81 2.23
Including 13.81 14.76 MiBC 0.95 4.00
PD-26-366 11.12 12.67 MiBC 1.55 1.64
Including 11.40 11.78 MiBC 0.38 2.97
PD-26-367 41.58 45.33 MiBC 3.75 0.54
Including 44.90 45.33 MiBC 0.43 2.67
PD-26-368 6.37 11.00 MiPC 4.63 0.40
and 17.53 19.95 MiBC 2.42 0.21
and 30.09 32.06 MiBC 1.97 0.56
PD-26-369 11.21 17.13 MiPC 5.92 0.50
Including 11.87 13.17 MiPC 1.30 1.29
and 25.80 29.70 MiBC 3.90 0.24
PD-26-370 13.00 18.08 MiPC 5.08 0.30
Including 13.89 14.20 MiPC 0.31 1.07
PD-26-371 10.31 13.85 MiPC 3.54 0.32
and 20.00 24.38 MiBC 4.38 0.21
PD-26-372 11.64 12.83 MiPC 1.19 1.14
and 15.62 17.02 MiPC 1.40 0.31
and 24.41 28.36 MiPC 3.95 0.37
Including 24.91 25.41 MiPC 0.50 1.28
and 47.30 50.65 MiBC 3.35 0.87
Including 47.76 49.27 MiBC 1.51 1.62
Including 47.76 48.11 MiBC 0.35 3.91
PD-26-373 10.48 14.55 MiPC 4.07 0.28
PD-26-375 7.79 14.50 MiPC 6.71 0.27
and 17.98 19.68 MiBS 1.70 0.43
PD-26-377 34.45 37.38 MiBC 2.93 0.98
Including 37.07 37.38 MiBC 0.31 7.67
PD-26-378 1.74 3.32 MiPC 1.58 0.23
and 11.50 12.48 MiBC 0.98 1.62
Including 12.12 12.48 MiBC 0.36 3.30
PD-26-379 7.62 9.90 MiBC 2.28 2.00
Including 8.42 9.42 MiBC 1.00 4.00
Including 8.42 8.72 MiBC 0.30 9.31
PD-26-381 14.04 15.48 MiBC 1.44 2.34
 Including 14.66 15.11 MiBC 0.45 4.60
PD-26-382 7.61 8.73 MiBC 1.12 1.37
 Including 8.11 8.43 MiBC 0.32 3.15
PD-26-383 7.74 12.26 MiBC 4.52 0.94
Including 10.76 12.26 MiBC 1.50 2.48
Including 11.26 11.76 MiBC 0.50 4.78
PD-26-385 7.00 8.75 MiBC 1.75 0.36
PD-26-387 14.00 15.93 MiBC 1.93 0.38
PD-26-391 36.01 37.63 MiBC 1.62 0.38
PD-26-392 2.00 4.00 MiPC 2.00 0.26
and 8.00 12.06 MiPC 4.06 0.25
and 31.10 35.44 MiBC 4.34 0.32
and 37.63 40.10 MaC 2.47 0.35
PD-26-396 7.52 11.95 MiPC 4.43 0.25
and 27.00 29.00 MiBS 2.00 0.22
and 31.05 34.58 MiBC 3.53 0.28
and 37.47 39.42 MaC 1.95 0.26
PD-26-397 38.59 41.40 MiBC 2.81 0.89
Including 39.09 39.50 MiBC 0.41 3.32
PD-26-399 14.71 18.17 MiPC 3.46 0.33
Including 15.67 16.17 MiPC 0.50 1.29
and 36.00 41.76 MiBC 5.76 0.23
Including 36.44 36.94 MiBC 0.50 1.08
and 40.28 41.76 MiBC 1.48 0.25
PD-26-426 27.30 33.90 MiBS-MiBC 6.60 0.40
Including 32.00 33.90 MiBC 1.90 0.66
PD-26-427 6.90 9.60 MiPC 2.70 0.32
and 34.60 38.77 MiBC 4.17 0.25
PD-26-429 29.06 32.10 MiBS 3.04 0.34

1 MiBC – Main Layer; MaC – Matinenda Layer; MiPC – Upper Conglomerate Layer; MiBS – Upper Sandstone.
2Interval width is approximate true thickness. Mineralization has a flat to 5-degree dip, and all holes were drilled vertically with an inclination of -90 degrees.

Table 2. Details of Phase 2 drill hole locations reported.

Drill Hole Inclination
(Degrees)
Length
(Metres)
Northing
(UTM)
Easting
(UTM)
PD-26-301 -90 34.00 5183157 555814
PD-26-302 -90 38.50 5183138 555836
PD-26-303 -90 40.00 5183162 555837
PD-26-304 -90 38.50 5183190 555837
PD-26-305 -90 41.50 5183221 555839
PD-26-306 -90 36.50 5183251 555837
PD-26-307 -90 58.00 5183326 555911
PD-26-308 -90 56.50 5183272 555909
PD-26-309 -90 50.50 5183219 555896
PD-26-310 -90 46.00 5183162 555898
PD-26-311 -90 43.00 5183107 555896
PD-26-312 -90 47.50 5183109 555951
PD-26-313 -90 49.00 5183159 555955
PD-26-314 -90 58.00 5183220 555956
PD-26-315 -90 50.50 5183275 555967
PD-26-316 -90 49.00 5183176 555983
PD-26-317 -90 44.50 5183234 555991
PD-26-318 -90 43.00 5183259 556002
PD-26-319 -90 46.00 5183319 556025
PD-26-320 -90 43.00 5183284 556016
PD-26-321 -90 53.50 5183327 555966
PD-26-322 -90 19.00 5183135 556023
PD-26-323 -90 26.50 5183161 556012
PD-26-324 -90 25.00 5183221 556037
PD-26-325 -90 23.50 5183262 556058
PD-26-326 -90 12.00 5183448 556335
PD-26-327 -90 13.50 5183449 556320
PD-26-328 -90 15.29 5183432 556321
PD-26-329 -90 15.00 5183419 556337
PD-26-330 -90 13.50 5183415 556326
PD-26-331 -90 18.00 5183360 556306
PD-26-332 -90 13.50 5183347 556291
PD-26-333 -90 11.50 5183206 556443
PD-26-334 -90 13.00 5183189 556476
PD-26-335 -90 10.00 5183213 556512
PD-26-336 -90 40.00 5183197 556566
PD-26-337 -90 43.16 5183323 556667
PD-26-338 -90 44.50 5183237 556599
PD-26-339 -90 47.00 5183277 556663
PD-26-340 -90 49.00 5183277 556614
PD-26-341 -90 48.45 5183240 556662
PD-26-342 -90 49.00 5183196 556627
PD-26-343 -90 6.00 5183355 556467
PD-26-344 -90 6.00 5183367 556483
PD-26-345 -90 7.50 5183353 556485
PD-26-346 -90 7.50 5183368 556495
PD-26-347 -90 9.00 5183353 556495
PD-26-348 -90 10.50 5183338 556497
PD-26-349 -90 7.50 5183318 556495
PD-26-350 -90 10.50 5183336 556510
PD-26-351 -90 7.50 5183353 556512
PD-26-352 -90 7.50 5183368 556515
PD-26-353 -90 7.50 5183383 556511
PD-26-354 -90 5.50 5183315 556455
PD-26-355 -90 4.50 5183304 556454
PD-26-356 -90 6.00 5183281 556455
PD-26-357 -90 7.50 5183290 556453
PD-26-358 -90 12.00 5183370 556205
PD-26-359 -90 13.50 5183376 556175
PD-26-360 -90 13.50 5183383 556161
PD-26-361 -90 16.50 5183381 556147
PD-26-362 -90 17.00 5183407 556162
PD-26-363 -90 16.50 5183411 556146
PD-26-364 -90 15.00 5183425 556162
PD-26-365 -90 16.50 5183440 556146
PD-26-366 -90 15.00 5183439 556163
PD-26-367 -90 51.00 5183071 556539
PD-26-368 -90 44.50 5183018 556539
PD-26-369 -90 50.50 5182961 556535
PD-26-370 -90 55.10 5182900 556533
PD-26-371 -90 41.50 5182841 556533
PD-26-372 -90 55.10 5182773 556587
PD-26-373 -90 52.00 5182840 556596
PD-26-374 -90 55.10 5182897 556596
PD-26-375 -90 53.50 5182959 556597
PD-26-376 -90 48.71 5183009 556619
PD-26-377 -90 49.00 5183079 556602
PD-26-378 -90 15.00 5183449 556193
PD-26-379 -90 13.50 5183460 556208
PD-26-380 -90 19.50 5183461 556226
PD-26-381 -90 18.00 5183461 556243
PD-26-382 -90 10.50 5183464 556261
PD-26-383 -90 13.50 5183446 556309
PD-26-384 -90 12.00 5183448 556290
PD-26-385 -90 10.50 5183449 556274
PD-26-386 -90 15.00 5183451 556257
PD-26-387 -90 18.00 5183447 556227
PD-26-391 -90 47.50 5183137 556628
PD-26-392 -90 41.67 5183271 556709
PD-26-393 -90 34.00 5183244 556905
PD-26-394 -90 35.29 5183364 556874
PD-26-395 -90 25.09 5183309 556904
PD-26-396 -90 41.50 5183240 556708
PD-26-397 -90 55.50 5183080 556676
PD-26-398 -90 50.50 5183139 556671
PD-26-399 -90 52.00 5183202 556674
PD-26-426 -90 46.00 5183139 556726
PD-26-427 -90 41.50 5183193 556732
PD-26-428 -90 44.50 5183084 556725
PD-26-429 -90 49.00 5183018 556722


About Inventus Mining Corp.

Inventus is a mineral exploration and development company focused on the world-class mining district of Sudbury, Ontario. We have a 100% interest in our principal assets, the Pardo Paleoplacer Gold Project and the Sudbury 2.0 Critical Mineral Project, located northeast of Sudbury. The Pardo Gold Project is the first important paleoplacer gold discovery in North America. Inventus has approximately 221 million common shares outstanding.

Qualified Person

The Qualified Person responsible for the technical content of this news release is Wesley Whymark, P.Geo., who has reviewed and approved the technical disclosure in this news release on behalf of the Company.

Technical Information

Drill core samples collected by Inventus and described in this news release were subject to robust QA/QC protocols. PQ-size drill core was placed in core boxes by the contracted drill crew and then transported by Inventus personnel to a secure processing facility in Sudbury, Ontario. The core was reviewed, with core metreage blocks checked to verify core integrity and recovery, geologically logged, and sample intervals marked. Whole-core samples were then photographed and inserted into clean plastic bags with sample tags. Certified reference materials were inserted into the sample stream at a rate of no less than 10%.

Samples were then transported in secure sealed bags with security tags for preparation and assay by MSA Labs or Paragon Geochemical in Timmins, Ontario. Samples were processed, whereby the entire sample was crushed to 80% passing 2 mm and then riffle split into two (2) or three (3) 300- to 500-g jars for gold analysis by PhotonAssay. Duplicate or triplicate samples were analyzed, and the results averaged. MSA Labs and Paragon Geochemical are both an ISO 17025:2017 accredited geochemical testing laboratory.

Forward-Looking Statements

This News Release includes certain “forward-looking statements” which are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “if”, “yet”, “potential”, “undetermined”, “objective”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes, but is not limited to, the Company’s objectives, goals or future plans, statements, exploration results, potential mineralization, the estimation of mineral resources, exploration and mine development plans, timing of the commencement of operations and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to the failure to identify mineral resources, failure to convert estimated mineral resources to reserves, the inability to complete a feasibility study which recommends a production decision, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, inability to fulfill the duty to accommodate First Nations and other indigenous peoples, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry, and those risks set out in the Company’s public documents filed on SEDAR+. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/b60ffb62-bdcd-4a06-8cbf-403a1fc2e987
https://www.globenewswire.com/NewsRoom/AttachmentNg/df69534d-ec0e-4939-97ea-e9ea6d26f743

John Chambers, PhD, and Nilanjana Sadhu, PhD, to share early insights from pioneering population-scale proteomic study of 10,000 participants in Singapore

REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER) today announced that researchers from Nanyang Technological University will present early findings from the PRECISE-SG100K study at the 2026 Human Proteome Organization (HUPO) World Congress, taking place September 27 to October 1 at the Suntec Singapore Convention & Exhibition Centre.

Led by John Chambers, PhD, Chief Scientific Officer of PRECISE and Lead PI of PRECISE-SG100K, the study represents an ambitious effort to bring deep molecular characterization to population health at unprecedented scale. By integrating proteomic data with genomic, clinical and phenotypic information from Singapore’s multi-ethnic population, PRECISE-SG100K is creating a uniquely rich resource for understanding how biological and population-level differences contribute to health and disease.

As the PRECISE-SG100K program evolved, the investigators expanded its proteomic strategy to include deep, unbiased mass spectrometry-based profiling in 10,000 participants. This complementary arm of the study combines Seer’s Proteograph® Product Suite with high-performance liquid chromatography-mass spectrometry (LC-MS), enabling researchers to interrogate the circulating proteome across a broad dynamic range and at peptide-level resolution. The approach provides an important discovery dimension to the study, allowing investigators to look beyond predefined protein targets and explore biological signals that may not have been anticipated at the outset.

In April 2026, Seer announced that the Proteograph Product Suite had been selected for this 10,000-participant component of PRECISE-SG100K. By enriching proteins across the enormous dynamic range of plasma before mass spectrometry analysis, Proteograph can increase the depth of protein coverage by approximately 7 to 10-fold compared with direct plasma analysis on leading mass spectrometry platforms. That additional depth brings into view lower-abundance proteins and potential biomarkers that can otherwise go undetected, while preserving the peptide-level information needed to investigate protein variants and other molecular differences.

For population-scale studies, depth alone is not enough. Biological signals must also be measured robustly and reproducibly across thousands of samples. The Proteograph workflow is designed to deliver consistent sample processing and high-quality proteomic data at scale, helping investigators distinguish meaningful biological variation from technical variability and increasing confidence in the signals identified across the cohort.

“As biology enters the AI era, the value of our models will ultimately depend on the richness and resolution of the biological data we can generate,” said Omid Farokhzad, Chair and Chief Executive Officer of Seer. “Proteins are the functional layer of biology, yet the plasma proteome spans an extraordinary dynamic range, and many potentially important disease signals are present at low abundance. Proteograph changes what mass spectrometry can see. John Chambers and the PRECISE-SG100K team have created a pioneering study that brings together population scale, diversity and deep, peptide-resolved proteomics in a way that can uncover biology that might otherwise remain hidden.”

“The combination of Proteograph enrichment and high-performance mass spectrometry has allowed us to interrogate the circulating proteome with a level of depth, consistency and reproducibility, and to bring deep biological resolution to population-scale analysis,” said John Chambers, PhD, Chief Scientific Officer of PRECISE and Lead PI of the PRECISE-SG100K study. “The proteomic data generated using this technology are already revealing proteogenomic and epidemiological signals and show strong potential to accelerate biomarker discovery and broaden the reach of precision medicine.”

Seer Breakfast Symposium

Mass Spectrometry-based Proteomics in Asian Cohort Studies: Opportunities and Challenges

Date: Monday, September 28, 2026 | Time: 7:45-8:45 a.m. SGT | Location: Room 330, Level 3

Speakers:

John Chambers, PhD, Professor, Nanyang Technological University, Singapore; Chief Scientific Officer of PRECISE and Lead PI of the PRECISE-SG100K study

Nilanjana Sadhu, PhD, Research Assistant Professor, Nanyang Technological University, Singapore; Proteomic Working Group Lead of the PRECISE-SG100K study

The PRECISE-SG100K study is a landmark effort in precision health, designed to capture genetic, molecular, clinical and phenotypic diversity across Singapore’s multi-ethnic population. As part of its broader proteomic strategy, the study incorporated the Seer Proteograph workflow combined with Thermo Scientific Orbitrap Astral™ mass spectrometry to deeply characterize the circulating proteome of 10,000 individuals. Early proteogenomic and epidemiological findings will provide a first look at the additional biological insights enabled by deep, unbiased, mass spectrometry-based proteomics at population scale.

Seer Poster Presentation

From Peaks to Power: Context-Driven Determinants of Accuracy in Large-Scale Proteomics

Date: Wednesday, September 30, 2026 | Time: 1:15 p.m. SGT | Location: Exhibit Hall | Session: PS03.002

Presenter: Lee Cantrell, Bioinformatics Scientist III, Seer

Authors: Lee Cantrell, Seth Just, Serafim Batzoglou

Population-scale proteomics creates the opportunity to make statistically powered, in-depth biological observations across large cohorts. Realizing that opportunity requires more than depth alone: quantitative fidelity and reproducibility must be maintained as studies scale. This poster examines the acquisition context required to preserve biological signal across large numbers of samples and what those requirements mean for the design of large clinical and population studies.

Together, the presentations illustrate both the scientific ambition and the technical requirements of a new generation of population proteomics studies. PRECISE-SG100K demonstrates what becomes possible when deep, peptide-resolved mass spectrometry is incorporated into a richly characterized, multi-ethnic population cohort, while From Peaks to Power examines what is required to preserve quantitative fidelity as studies reach this scale. Together, they point toward proteomic datasets with the breadth, depth and reproducibility needed to support biomarker discovery, population health research and increasingly data-intensive approaches to biology.

For more information, please visit Booth #232 at the HUPO World Congress.

About Seer, Inc.

Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

About PRECISE-SG100K Study

The PRECISE-SG100K study is a landmark, long-term research project that has completed recruitment of over 100,0001 participants from Singapore’s diverse, multi-ethnic population. The study has collected extensive baseline health information and biological specimens and will continue to monitor long-term health outcomes and the environmental, lifestyle and genetic factors associated with diseases such as diabetes, hypertension and cancer. As one of the largest population health studies in Southeast Asia, PRECISE-SG100K is designed to advance precision medicine and improve health outcomes for diverse populations worldwide.

For more information, visit www.npm.sg.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding Seer’s expectations about the PRECISE-SG100K collaboration, population-scale proteomics studies, and the impact of Seer’s products. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission and other documents that Seer subsequently files with the Securities and Exchange Commission from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Media Contact

Patrick Schmidt
pr@seer.bio

Investor Contact

Marissa Bych
investor@seer.bio

______________________________
1 NTD: Above we say 10,000 individuals. Confirm this 100,000 figure is distinct.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.